Soluble forms and ligands of the receptor for advanced glycation end-products in patients with acute respiratory distress syndrome: An observational prospective study

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Jabaudon, Matthieu ^a,b   Blondonnet, Raiko ^a,b   Roszyk, Laurence ^a,b   Pereira, Bruno ^a   Guérin, Renaud ^a   Perbet, Sébastien ^a,b   Cayot, Sophie ^a   Bouvier, Damien ^a,b   Blanchon, Loic ^b   Sapin, Vincent ^a,b   Constantin, Jean Michel ^a,b  

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; CALCIUM BINDING PROTEIN; CISATRACURIUM; CORTICOSTEROID; HIGH MOBILITY GROUP B1 PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; S100 CALCIUM BINDING PROTEIN A12; UNCLASSIFIED DRUG; AGER PROTEIN, HUMAN; CALGRANULIN C; HMGB1 PROTEIN, HUMAN; S100A12 PROTEIN, HUMAN;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; BLOOD OXYGEN TENSION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; LUNG STRUCTURE; MALE; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; AGED; BLOOD; CLINICAL TRIAL; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TIME FACTOR;

ADULT; ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; AGED; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HMGB1 PROTEIN; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RESPIRATORY DISTRESS SYNDROME, ADULT; S100A12 PROTEIN; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 84942895101     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0135857     Document Type: Article

References (34)

1. Brun-Buisson C, Minelli C, Bertolini G, Brazzi L, Pimentel J, Lewandowski K, et al. Epidemiology and outcome of acute lung injury in European intensive care units. Results from the ALIVE study. Intensive Care Med. 2004; 30(1): 51-61. doi: 10.1007/s00134-003-2022-6 PMID: 14569423.
2. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, et al. Incidence and outcomes of acute lung injury. N Engl J Med. 2005; 353(16): 1685-93. doi: 10.1056/NEJMoa050333 PMID: 16236739.
3. Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, et al. Acute respiratory distress syndrome: The Berlin Definition. JAMA. 2012; 307(23): 2526-33. doi: 10.1001/jama.2012.5669 PMID: 22797452.
4. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000; 342(18): 1334-49. doi: 10.1056/NEJM200005043421806 PMID: 10793167.
5. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med. 2000; 342(18): 1301-8. doi: 10.1056/NEJM200005043421801 PMID: 10793162.
6. Papazian L, Forel JM, Gacouin A, Penot-Ragon C, Perrin G, Loundou A, et al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med. 2010; 363(12): 1107-16. doi: 10.1056/NEJMoa1005372 PMID: 20843245.
7. Guerin C, Reignier J, Richard JC, Beuret P, Gacouin A, Boulain T, et al. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med. 2013; 368(23): 2159-68. doi: 10.1056/NEJMoa1214103 PMID: 23688302.
8. Ware LB, Matthay MA. Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med. 2001; 163(6): 1376-83. doi: 10.1164/ajrccm.163.6.2004035 PMID: 11371404.
9. Shirasawa M, Naoyuki F, Susumu H, Hideki O, Junko I, Koshi M, et al. Receptor for advanced glycation end-products is a marker of type I lung alveolar cells. Genes to cells: Devoted to molecular & cellular mechanisms. 2004; 9(2): 165-74.
10. Uchida T, Shirasawa M, Ware LB, Kojima K, Hata Y, Makita K, et al. Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. Am J Respir Crit Care Med. 2006; 173 (9): 1008-15. doi: 10.1164/rccm.200509-1477OC PMID: 16456142; PubMed Central PMCID: PMC2662912.
11. Calfee CS, Ware LB, Eisner MD, Parsons PE, Thompson BT, Wickersham N, et al. Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury. Thorax. 2008; 63 (12): 1083-9. doi: 10.1136/thx.2008.095588 PMID: 18566109
12. Jabaudon M, Futier E, Roszyk L, Chalus E, Guerin R, Petit A, et al. Soluble form of the receptor for advanced glycation end products is a marker of acute lung injury but not of severe sepsis in critically ill patients. Crit Care Med. 2011; 39(3): 480-8. doi: 10.1097/CCM.0b013e318206b3ca PMID: 21220996.
13. Schmidt AM, Yan SD, Yan SF, Stern DM. The biology of the receptor for advanced glycation end products and its ligands. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research. 2000; 1498(2-3): 99-111. doi: 10.1016/s0167-4889(00)00087-2
14. Hanford LE, Enghild JJ, Valnickova Z, Petersen SV, Schaefer LM, Schaefer TM, et al. Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE). J Biol Chem. 2004; 279(48): 50019-24. doi: 10.1074/jbc.M409782200 PMID: 15381690; PubMed Central PMCID: PMC1868562.
15. Johnson MD, Widdicombe JH, Allen L, Barbry P, Dobbs LG. Alveolar epithelial type I cells contain transport proteins and transport sodium, supporting an active role for type I cells in regulation of lung liquid homeostasis. Proc Natl Acad Sci U S A. 2002; 99(4): 1966-71. doi: 10.1073/pnas.042689399 PMID: 11842214; PubMed Central PMCID: PMC122303.
16. Cheng C, Tsuneyama K, Kominami R, Shinohara H, Sakurai S, Yonekura H, et al. Expression profiling of endogenous secretory receptor for advanced glycation end products in human organs. Mod Pathol. 2005; 18(10): 1385-96. doi: 10.1038/modpathol.3800450. PMID: 15933755.
17. Yan SF, Barile GR, D'Agati V, Du Yan S, Ramasamy R, Schmidt AM. The biology of RAGE and its ligands: Uncovering mechanisms at the heart of diabetes and its complications. Curr Diab Rep. 2007; 7 (2): 146-53. PMID: 17425919.
18. Schmidt AM, Yan SD, Yan SF, Stern DM. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. Journal of Clinical Investigation. 2001; 108(7): 949-55. doi: 10.1172/jci200114002 PMID: 11581294
19. Taguchi A, Blood DC, del Toro G, Canet A, Lee DC, Qu W, et al. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature. 2000; 405(6784): 354-60. doi: 10.1038/35012626 PMID: 10830965.
20. Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, Lu Y, et al. RAGE mediates a novel proinflammatory axis: A central cell surface receptor for S100/calgranulin polypeptides. Cell. 1999; 97(7): 889-901. PMID: 10399917
21. Bierhaus A, Humpert PM, Morcos M, Wendt T, Chavakis T, Arnold B, et al. Understanding RAGE, the receptor for advanced glycation end products. J Mol Med (Berl). 2005; 83(11): 876-86. doi: 10.1007/s00109-005-0688-7 PMID: 16133426.
22. Geroldi D, Falcone C, Emanuele E. Soluble receptor for advanced glycation end products: From disease marker to potential therapeutic target. Current medicinal chemistry. 2006; 13(17): 1971-8. PMID: 16842191.
23. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008; 36(1): 296-327. doi: 10.1097/01.CCM.0000298158.12101.41 PMID: 18158437.
24. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. American Journal of Respiratory and Critical Care Medicine. 1994; 149(3 Pt 1): 818-24. doi: 10. 1164/ajrccm.149.3.7509706 PMID: 7509706
25. Malbouisson LM, Muller JC, Constantin JM, Lu Q, Puybasset L, Rouby JJ, et al. Computed tomography assessment of positive end-expiratory pressure-induced alveolar recruitment in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 2001; 163(6): 1444-50. doi: 10.1164/ajrccm. 163.6.2005001 PMID: 11371416.
26. Puybasset L, Cluzel P, Gusman P, Grenier P, Preteux F, Rouby JJ. Regional distribution of gas and tissue in acute respiratory distress syndrome. I. Consequences for lung morphology. CT Scan ARDS Study Group. Intensive Care Med. 2000; 26(7): 857-69. PMID: 10990099.
27. Constantin JM, Cayot-Constantin S, Roszyk L, Futier E, Sapin V, Dastugue B, et al. Response to recruitment maneuver influences net alveolar fluid clearance in acute respiratory distress syndrome. Anesthesiology. 2007; 106(5): 944-51. doi: 10.1097/01.anes.0000265153.17062.64 PMID: 17457125.
28. Matthay MA, Wiener-Kronish JP. Intact epithelial barrier function is critical for the resolution of alveolar edema in humans. The American review of respiratory disease. 1990; 142(6 Pt 1): 1250-7. doi: 10. 1164/ajrccm/142.6-Pt-1.1250 PMID: 2252240
29. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, N.J.: L. Erlbaum Associates; 1988. xxi, 567 p.
30. Pietzsch J, Hoppmann S. Human S100A12: A novel key player in inflammation? Amino Acids. 2009; 36 (3): 381-9. doi: 10.1007/s00726-008-0097-7 PMID: 18443896.
31. Nakamura T, Sato E, Fujiwara N, Kawagoe Y, Maeda S, Yamagishi S. Increased levels of soluble receptor for advanced glycation end products (sRAGE) and high mobility group box 1 (HMGB1) are associated with death in patients with acute respiratory distress syndrome. Clin Biochem. 2011; 44(8-9): 601-4. doi: 10.1016/j.clinbiochem.2010.12.014 PMID: 21211520.
32. Santilli F, Vazzana N, Bucciarelli LG, Davi G. Soluble forms of RAGE in human diseases: Clinical and therapeutical implications. Current medicinal chemistry. 2009; 16(8): 940-52. PMID: 19275604.
33. Colhoun HM, Betteridge DJ, Durrington P, Hitman G, Neil A, Livingstone S, et al. Total soluble and endogenous secretory receptor for advanced glycation end products as predictive biomarkers of coronary heart disease risk in patients with type 2 diabetes: An analysis from the CARDS trial. Diabetes. 2011; 60(9): 2379-85. doi: 10.2337/db11-0291 PMID: 21771973; PubMed Central PMCID: PMC3161327.
34. Schlueter C, Hauke S, Flohr AM, Rogalla P, Bullerdiek J. Tissue-specific expression patterns of the RAGE receptor and its soluble forms-A result of regulated alternative splicing? Biochim Biophys Acta. 2003; 1630(1): 1-6. PMID: 14580673.